Created by potrace 1.16, written by Peter Selinger 2001-2019beatandraise.com
Latest Financials

Filings:

CategoryDateSearch FilingsInstitutional HoldersbetaEarnings TranscriptsbetaGlobal Search

SEC Edgar

NYMOX PHARMACEUTICAL CORP

SIC 2835 · In Vitro & In Vivo Diagnostic Substances
NotesSupport
aboutterms
$NYMXF

NYMOX PHARMACEUTICAL CORP

CIK:0001018735|SEC Filings

MATERIAL CONTRACTS

EX-10.2
nymox_ex102.htm
2022-03-22T00:00:00Z
EX-10.1
nymox_ex101.htm
2022-03-22T00:00:00Z
EX-10.3
nymox_ex103.htm
2021-12-09T00:00:00Z
EX-10.1
nymox_ex101.htm
2021-12-09T00:00:00Z
EX-10.1
nymox_ex101.htm
2021-05-06T00:00:00Z
EX-10.3
nymox_ex103.htm
2021-05-06T00:00:00Z
EX-10.2
nymox_ex102.htm
2021-05-06T00:00:00Z
EX-10.1
nymox_ex101.htm
2020-08-14T00:00:00Z
EX-10.2
nymox_ex102.htm
2020-08-14T00:00:00Z
EX-10.6
EX-10.6.txt
1999-05-14T00:00:00Z
EX-10.10
EX-10.10.txt
2000-05-15T00:00:00Z
EX-10.1
EX-10.1.txt
2000-02-29T00:00:00Z
EX-10.4
EX-10.4.txt
1996-12-09T00:00:00Z
EX-10.3
EX-10.3.txt
1996-12-09T00:00:00Z
EX-10.1
sdc822a.htm
2004-11-16T00:00:00Z
EX-10.1
sdc556a.htm
2003-11-14T00:00:00Z
EX-10.0
irm208a.txt
2003-03-12T00:00:00Z
EX-10.7
slp314a.txt
2002-07-30T00:00:00Z